605 related articles for article (PubMed ID: 33187979)
1. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.
Mudd PA; Crawford JC; Turner JS; Souquette A; Reynolds D; Bender D; Bosanquet JP; Anand NJ; Striker DA; Martin RS; Boon ACM; House SL; Remy KE; Hotchkiss RS; Presti RM; O'Halloran JA; Powderly WG; Thomas PG; Ellebedy AH
Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33187979
[TBL] [Abstract][Full Text] [Related]
2. Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease.
Mudd PA; Crawford JC; Turner JS; Souquette A; Reynolds D; Bender D; Bosanquet JP; Anand NJ; Striker DA; Martin RS; Boon ACM; House SL; Remy KE; Hotchkiss RS; Presti RM; OHalloran JA; Powderly WG; Thomas PG; Ellebedy AH
medRxiv; 2020 May; ():. PubMed ID: 32511543
[TBL] [Abstract][Full Text] [Related]
3. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
Galani IE; Rovina N; Lampropoulou V; Triantafyllia V; Manioudaki M; Pavlos E; Koukaki E; Fragkou PC; Panou V; Rapti V; Koltsida O; Mentis A; Koulouris N; Tsiodras S; Koutsoukou A; Andreakos E
Nat Immunol; 2021 Jan; 22(1):32-40. PubMed ID: 33277638
[TBL] [Abstract][Full Text] [Related]
4. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
Xiao N; Nie M; Pang H; Wang B; Hu J; Meng X; Li K; Ran X; Long Q; Deng H; Chen N; Li S; Tang N; Huang A; Hu Z
Nat Commun; 2021 Mar; 12(1):1618. PubMed ID: 33712622
[TBL] [Abstract][Full Text] [Related]
5. Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19.
Gao Y; Wang C; Kang K; Peng Y; Luo Y; Liu H; Yang W; Zhao M; Yu K
Viral Immunol; 2021 Jun; 34(5):336-341. PubMed ID: 33202195
[TBL] [Abstract][Full Text] [Related]
6. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
Front Immunol; 2020; 11():603389. PubMed ID: 33552062
[TBL] [Abstract][Full Text] [Related]
7. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
Shi W; Liu X; Cao Q; Ma P; Le W; Xie L; Ye J; Wen W; Tang H; Su W; Zheng Y; Liu Y
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L84-L98. PubMed ID: 33146564
[TBL] [Abstract][Full Text] [Related]
8. An overview of proteomic methods for the study of 'cytokine storms'.
David P; Hansen FJ; Bhat A; Weber GF
Expert Rev Proteomics; 2021 Feb; 18(2):83-91. PubMed ID: 33849358
[No Abstract] [Full Text] [Related]
9. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
Choreño-Parra JA; Jiménez-Álvarez LA; Cruz-Lagunas A; Rodríguez-Reyna TS; Ramírez-Martínez G; Sandoval-Vega M; Hernández-García DL; Choreño-Parra EM; Balderas-Martínez YI; Martinez-Sánchez ME; Márquez-García E; Sciutto E; Moreno-Rodríguez J; Barreto-Rodríguez JO; Vázquez-Rojas H; Centeno-Sáenz GI; Alvarado-Peña N; Salinas-Lara C; Sánchez-Garibay C; Galeana-Cadena D; Hernández G; Mendoza-Milla C; Domínguez A; Granados J; Mena-Hernández L; Pérez-Buenfil LÁ; Domínguez-Cheritt G; Cabello-Gutiérrez C; Luna-Rivero C; Salas-Hernández J; Santillán-Doherty P; Regalado J; Hernández-Martínez A; Orozco L; Ávila-Moreno F; García-Latorre EA; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
Front Immunol; 2021; 12():593595. PubMed ID: 33995342
[TBL] [Abstract][Full Text] [Related]
11. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
Pinheiro MM; Fabbri A; Infante M
Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
[TBL] [Abstract][Full Text] [Related]
12. Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza.
Cambier S; Metzemaekers M; de Carvalho AC; Nooyens A; Jacobs C; Vanderbeke L; Malengier-Devlies B; Gouwy M; Heylen E; Meersseman P; Hermans G; Wauters E; Wilmer A; ; Schols D; Matthys P; Opdenakker G; Marques RE; Wauters J; Vandooren J; Proost P
JCI Insight; 2022 Jan; 7(1):. PubMed ID: 34793331
[TBL] [Abstract][Full Text] [Related]
13. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
Kang S; Tanaka T; Inoue H; Ono C; Hashimoto S; Kioi Y; Matsumoto H; Matsuura H; Matsubara T; Shimizu K; Ogura H; Matsuura Y; Kishimoto T
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22351-22356. PubMed ID: 32826331
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients.
Zhang J; Lin D; Li K; Ding X; Li L; Liu Y; Liu D; Lin J; Teng X; Li Y; Liu M; Shen J; Wang X; He D; Shi Y; Wang D; Xu J
Front Immunol; 2021; 12():716075. PubMed ID: 34394120
[TBL] [Abstract][Full Text] [Related]
15. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.
Thwaites RS; Sanchez Sevilla Uruchurtu A; Siggins MK; Liew F; Russell CD; Moore SC; Fairfield C; Carter E; Abrams S; Short CE; Thaventhiran T; Bergstrom E; Gardener Z; Ascough S; Chiu C; Docherty AB; Hunt D; Crow YJ; Solomon T; Taylor GP; Turtle L; Harrison EM; Dunning J; Semple MG; Baillie JK; Openshaw PJ;
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33692097
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
18. Tackling the COVID-19 "cytokine storm" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs.
Gasparello J; Finotti A; Gambari R
Med Hypotheses; 2021 Jan; 146():110415. PubMed ID: 33422363
[TBL] [Abstract][Full Text] [Related]
19. The Mechanism behind Influenza Virus Cytokine Storm.
Gu Y; Zuo X; Zhang S; Ouyang Z; Jiang S; Wang F; Wang G
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372568
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
Lee JS; Park S; Jeong HW; Ahn JY; Choi SJ; Lee H; Choi B; Nam SK; Sa M; Kwon JS; Jeong SJ; Lee HK; Park SH; Park SH; Choi JY; Kim SH; Jung I; Shin EC
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32651212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
